期刊文献+

不稳定型心绞痛患者冠脉介入术前后N末端脑钠肽前体水平的变化 被引量:4

Changes of N-terminal pro-brain natriuretic peptide in unstable angina pectoris undergone with percutaneous coronary intervention
下载PDF
导出
摘要 目的 观察冠脉介入前、后不稳定型心绞痛(UAP)患者N末端脑钠肽前体(NT-proBNP)水平变化,探讨心肌缺血与NT-proBNP的关系.方法 选择心功能正常的UAP患者75例,胸痛症状无发作3 d以上时行冠状动脉造影检查,病变适宜者接受经皮冠状动脉介入治疗.术前及术后16~24 h进行超声心动图检查和血浆NT-proBNP浓度测定,术后72 h复查血浆NT-proBNP水平.结果 单纯冠脉造影(CAG组)37例,经皮冠状动脉介入治疗(PCI组)38例,其中单支病变28例,包括左冠状动脉前降支置入支架(LAD组)18例、右冠状动脉或回旋支置入支架(非LAD组)10例.CAG组术前和术后16~24 h的NT-proBNP水平及左室射血分数(LVEF)无明显变化(P>0.05);PCI组术后16~24 h的血浆NT-proBNP浓度高于术前(P<0.05),LVEF较术前降低,但差异无统计学意义(P>0.05);LAD组的NT-proBNP升高幅度大于非LAD组(P<0.05),两组术后72 h的NT-proBNP水平均低于术前(P<0.05).结论 在心功能正常且无明显改变的情况下,UAP患者介入治疗后血浆NT-proBNP浓度暂时升高,可能与术中球囊扩张所致的一过性心肌缺血有关.心肌缺血是刺激NT-proBNP分泌增多的重要因素. Objective To observe the changes of plasma N-terminal pro-brain natriuretic poptide (NT- proBNP) in unstable angina pectoris (UAP) underwent with coronary intervention, and evaluate the association between ischemic and NT-proBNP. Methods We enrolled a total of 75 patients with UAP and normal left ventricular function. Coronary angiography(CAG) for all patients and percutaneous coronary intervention (PCI) for part patients with suitable conditions were performed 3 days or above after the last chest pain. Plasma NT-proBNF and echocardiography were determined before and 16-24 hours after intervention. NT-proBNP was measured again 72 hours post intervention. Results 37 patients with CAG and 38 with PCI. The later contained 28 patients with one-vessel coronary disease, including 18 accepted stentt implantation in left anterior descending coronary artery (LAD group) and 10 in left circumflex or right coronary artery (non-LAD group). No significant change in NT- proBNP and LVEF were noted before and 16-24 hours after simple CAG(P〉0.05). NT-proBNP concentration was higher 16-24 hours after PCI than before (P〈0.05), some decrease in left ventricular ejection fraction (LVEF) was not statistically significant (P〉0.05). NT-proBNP showed a larger increase in the LAD group compared to the non-LAD group (P〈0.05). NT-proBNP 72 hours post intervention was markedly lower than before in all patients (P〈0.05). Conclusion Patients with UAP and preserved cardiac function have higher NT-proBNP levels after PCI, which is related to myocardial ischemia induced by balloon inflation during PCI. Myocardial ischemia is probably an important stimulus for NT-proBNP release.
出处 《中国心血管病研究》 CAS 2011年第12期922-924,共3页 Chinese Journal of Cardiovascular Research
关键词 N末端脑钠肽前体 不稳定型心绞痛 经皮冠状动脉介入治疗 N-terminal pro-brain natriuretic peptide Unstable angina pectoris Percutaneous coronary ntervention
  • 相关文献

参考文献7

  • 1Staub D,Jonas N,Zellweger MJ,et al.Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia.Am J Med,2005,118:1287.
  • 2Schiano P,Revel F,Hemery Y,et al.Increased secretion of Nt-proBNP immediately after percutaneous coronary intervention:about 90 cases.Ann Cardiol Angeiol,2007,56:117-121.
  • 3周丽程,郑杨.脑钠素、N-末端脑钠素前体与心血管疾病[J].中国心血管病研究,2007,5(12):937-939. 被引量:11
  • 4Januzzi JL,van Kimmenade R,Lainchbury J,et al.NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure:an international pooled analysis of 1256 patients:the International Collaborative of NT-proBNP Study.Eur Heart J,2006,27:330-337.
  • 5McCullough PA,Peacock WF,O'Neil B,et al.An evidence-based algorithm for the use of B-type natriuretic testing in acute coronary syndromes.Rev Cardiovasc Med,2010,11:S51-65.
  • 6刘访遥,雷长城.氮末端脑利钠肽与急性冠脉综合征的关系[J].中国心血管病研究,2006,4(12):944-946. 被引量:4
  • 7章体玲,光雪峰.急性冠脉综合征脑钠肽及N-末端脑钠素原水平变化及意义[J].中国心血管病研究,2006,4(11):869-871. 被引量:1

二级参考文献49

  • 1肖春晖,吴小庆,羊镇宇,李肖蓉,王如兴.B型利钠肽与孤立性心房颤动[J].中国循环杂志,2007,22(1):31-34. 被引量:12
  • 2[1]Ridker PM,Hennekens CH,Stampfer MJ,et al.Plasma concentration of soluble Intercellular adhesion molecule 1 and risks of future myocardial in apparently healthy men.Lancet,1998,351:88.
  • 3[2]Omland T,Persson A,Leong NG,et al.N-Terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes.Circulation,2002,106:2913.
  • 4[3]Leroy G,Uzan L,Bugugnani MJ,et al.The value of repeated determinations of brain natriuretic peptide for the diagnosis of unstable angina.Arch Mal Coeur Vaiss.2003,96:305-310.
  • 5[4]Eui-Young C,Hyuck Moon Kwon,et al.Assessment of extent of myocardial ischemia in patients with non-ST elevation acute coronary syndrome using serum B-type natriuretic peptide level.Yonsei Medical,2004,45:255-262.
  • 6[5]Scott J,Cameron,Gary B,et al.Assessment of BNP and NT-proBNP in emergency department patients presenting with suspected acute coronary syndromes.Clinical Biochemistry,2006,39:11-18.
  • 7[6]Christopher H,Christian W,Veselin M,et al.N-terminal proB-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.Circulation,2004,110:128-134.
  • 8[7]David A,Morrow,James A,et al.Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/Non-ST-elevation myocardial Infarction:B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.Am Coll Cardiol,2003,41:1264 -1272.
  • 9[8]Talwar S,Squire IB,Downie PF,et al.Profile of plasma N-terminal proBNP following acute myocardial infarction correlation with left ventricular systolic dysfunction.Eur Heart,2000,21:1514-1521.
  • 10[9]Richards AM,Nicholls MG,Yandle TG,et al.Related articles,links plasma N-terminalpro-brain natriuretic peptide and adrenomedullin:new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.Circulation,1998,97:1921-1929.

共引文献13

同被引文献46

  • 1刘梅林,李继敏,胡大一,马志敏,高霖,庞永正.心绞痛患者血浆N-proBNP水平的变化及其临床意义[J].中华心血管病杂志,2004,32(6):497-500. 被引量:66
  • 2周南南,朱兴雷,叶琳,王建春.氮末端脑钠肽前体与急性心肌梗死近期预后的关系[J].山东大学学报(医学版),2006,44(9):872-874. 被引量:5
  • 3柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2157
  • 4Omland T,Persson A,Leong NG,et a1.N-terminal pro-B-type natriureticand long time mortality in acute coronary syndromes[J].Circulation,2002,106(23):2913-2918.
  • 5Sinnaeve PR,Ezekowitz JA,Bogaerts K,et al.Reperfusion before percu-taneous coronary intervention in ST-elevation myocardial inparction pa-tients is associated with lower N-terminal probrain natriuretic peptide lev-els during follow-up,irrespective of pre-treatment with full-dose fibrinoly-sis[J].Eur Heart,2009,30:2213-2219.
  • 6Schiano P,Revel F,Hemery Y,et al.Incrrased secretion of Nt-proBNPimmediately after percutaneous coronary intervention:about 90 cases[J].Ann Cardiol Angeiol,2007,56:117-121.
  • 7Kelly R,Stmthem AD.Are natiuretic peptide clinically useful as mark-ers of heart failure?[J].Ann Clin Biochem,2001,38(2):94-102.
  • 8Januzzi JI,Camargo CA,Anwaruddins,et al.The N-terminal Pro-BNPinvestigation of dyspnea in the emergency department(PRDE)study[J].Am J Cardiol,2005,95(8):948-954.
  • 9Troughton RW,Richards AM.Outpatient monitoring and treatment ofchronic heart failure guided by amino-tenminal pro-B-type natriureticpeptide measurement[J].Am J Cardiol,2008,101(3A):72-75.
  • 10Galvani M,Ottani F,Oltrona L,et al.N-terminal pro-Brain natriureticpeptide on admission has prognostic value across the whole spectrum ofacute coronary syndromes[J].Circulation,2004,110:128-134.

引证文献4

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部